Acer Therapeutics Inc.·4

Mar 16, 4:35 PM ET

DUNN JOHN MICHAEL 4

4 · Acer Therapeutics Inc. · Filed Mar 16, 2023

Insider Transaction Report

Form 4
Period: 2023-03-14
Transactions
  • Award

    Stock Option (right to buy)

    2023-03-14+20,00020,000 total
    Exercise: $1.67Exp: 2033-03-14Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The option, which is made as part of the Issuer's 2023 annual compensation cycle, vests and becomes exercisable in full on March 14, 2024.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION